SEPTRA Side Effects

6964814-6 | Hypersensitivity, Thrombocytopenic Purpura
on Aug 31, 2010 Female patient from UNITED STATES , 46 years of age, was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, thrombocytopenic purpura. Septra dosage: Unk.

6964812-2 | Rash Erythematous, Rash Pustular
Patient was taking Septra (View Usage). Patient had the following side effects: rash erythematous, rash pustular on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with infection prophylaxis and. Septra dosage: Unk. During the same period patient was treated with VALACYCLOVIR (Unk) (View Valacyclovir Review and Valacyclovir Label ), FLUCONAZOLE (Unk) (View Fluconazole Review and Fluconazole Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ), REGULAR INSULIN (Unk) (View Regular Insulin Review and Regular Insulin Label ), HEPARIN (Unk) (View Heparin Review and Heparin Label ).

6944610-6 | Hypersensitivity, Thrombocytopenic Purpura
Adverse event was reported on Aug 17, 2010 by a Female patient taking Septra (View Usage) (Dosage: Unk) . Location: UNITED STATES , 46 years of age, After Septra was administered, patient had the following side effects: hypersensitivity, thrombocytopenic purpura.

6936045-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Decreased Appetite, Erythema, Headache, Hypersensitivity, Nausea, Pyrexia, Tremor
on Jun 30, 2010 Female patient from UNITED STATES , 41 years of age, weighting 126.0 lb, was diagnosed with infection (What is infection?), pain (What is pain?) and was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased appetite, erythema, headache (What is headache?), hypersensitivity, nausea (What is nausea?), pyrexia, tremor. Septra dosage: Unk, Bid. During the same period patient was treated with VICODIN (5-500 Mg, Prn) (View Vicodin Review and Vicodin Label ).


6936044-5 | Neutropenia
on Jun 14, 2010 Female patient from UNITED STATES , 17 years of age, weighting 124.1 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), non-small cell lung cancer and was treated with Septra (View Usage). Patient had the following side effects: neutropenia. Septra dosage: 800/160 Mg, Bid. During the same period patient was treated with ANTINEOPLASTIC AGENTS (165 Mg/m2, Bid) (View Antineoplastic Agents Review and Antineoplastic Agents Label ), CEFEPIME (View Cefepime Review and Cefepime Label ).

6936029-9 | Dark Circles Under Eyes, Myalgia, Ocular Icterus, Pain, Pyrexia, Urticaria
Patient was taking Septra (View Usage). After Septra was administered, patient had the following side effects: dark circles under eyes, myalgia, ocular icterus, pain (What is pain?), pyrexia, urticaria on Oct 22, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 128.0 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Septra dosage: Unk.

6936028-7 | Erythema Multiforme
Adverse event was reported on Aug 28, 2009 by a Female patient taking Septra (View Usage) (Dosage: Bid) was diagnosed with vaginal infection, hypertension, blood cholesterol increased and. Location: UNITED STATES , 82 years of age, Patient experienced the following unwanted or unexpected effects: erythema multiforme. During the same period patient was treated with VITAMINS (Unk) (View Vitamins Review and Vitamins Label ), ALTACE (Unk) (View Altace Review and Altace Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ).

6936026-3 | Oesophageal Spasm
on Feb 05, 2010 Female patient from UNITED STATES , weighting 296.9 lb, was treated with Septra (View Usage). Patient had the following side effects: oesophageal spasm. Septra dosage: Unk.

6936022-6 | Hypersensitivity, Pruritus
on Feb 23, 2010 Female patient from UNITED STATES , 54 years of age, was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: hypersensitivity, pruritus. Septra dosage: Unk.

6931504-5 | Dysarthria, Facial Paresis, Hemiparesis, Hypoaesthesia Oral, Swelling Face
Patient was taking Septra (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, facial paresis, hemiparesis, hypoaesthesia oral, swelling face on Aug 09, 2010 from BELGIUM Additional patient health information: Male patient , 13 years of age, weighting 134.5 lb, was diagnosed with oral disorder, oesophageal disorder, acute lymphocytic leukaemia and. Septra dosage: 800 Mg, Qd. During the same period patient was treated with OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), METHOTREXATE (12 Mg, Single) (View Methotrexate Review and Methotrexate Label ), CYTARABINE (30 Mg, Single) (View Cytarabine Review and Cytarabine Label ), CYCLOPHOSPHAMIDE (1000 Mg/m2, Single) (View Cyclophosphamide Review and Cyclophosphamide Label ), THIOGUANINE (60 Mg/m2, Qd) (View Thioguanine Review and Thioguanine Label ). Patient was hospitalized.

6814359-9 | Acute Respiratory Failure, Hypotension, Oxygen Saturation Decreased, Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Jun 28, 2010 by a Female patient taking Septra (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 47 years of age, Patient had the following side effects: acute respiratory failure, hypotension, oxygen saturation decreased, pneumocystis jiroveci pneumonia. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), PIPERACILLIN SODIUM W/TAZOBACTAM (View Piperacillin Sodium W/tazobactam Review and Piperacillin Sodium W/tazobactam Label ). Patient was hospitalized.

6810176-4 | Aphasia, Hypoglycaemia
on Jun 21, 2010 Male patient from FRANCE , 76 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), diabetes mellitus and was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: aphasia (What is aphasia?), hypoglycaemia. Septra dosage: 160/800 Mg, Qd. During the same period patient was treated with REPAGLINIDE (1 Mg, Tid) (View Repaglinide Review and Repaglinide Label ), AMIODARONE (200 Mg, Qd) (View Amiodarone Review and Amiodarone Label ), PERINDOPRIL (2 Mg, Qd) (View Perindopril Review and Perindopril Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), ESOMEPRAZOLE MAGNESIUM (20 Mg, Qd) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

6785788-7 | Confusional State, Dysuria, Hyperhidrosis, Hypophagia, Nausea, Rash, Sepsis, Thrombocytopenia
on Jun 22, 2010 Female patient from UNITED STATES , 72 years of age, weighting 112.4 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, dysuria, hyperhidrosis, hypophagia, nausea (What is nausea?), rash (What is rash?), sepsis (What is sepsis?), thrombocytopenia. Septra dosage: Bid Po Recent. During the same period patient was treated with OSCAL (View Oscal Review and Oscal Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), NYSTATIN TOPICAL POWDER (View Nystatin Topical Powder Review and Nystatin Topical Powder Label ), ZOFRAN (View Zofran Review and Zofran Label ), K+ PROTOCOL (View K+ Protocol Review and K+ Protocol Label ). Patient was hospitalized.

6785525-6 | Asthenia, International Normalised Ratio Abnormal, Pneumonia, Pyrexia, Renal Failure
Patient was taking Septra (View Usage). Patient had the following side effects: asthenia, international normalised ratio abnormal, pneumonia (What is pneumonia?), pyrexia, renal failure on Jun 21, 2010 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 251.1 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Septra dosage: 1 Tab Bid Po. During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ZOCOR (View Zocor Review and Zocor Label ), DARVOCET (View Darvocet Review and Darvocet Label ), COZAAR (View Cozaar Review and Cozaar Label ), LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6783341-2 | Bradycardia, Decreased Appetite, Dizziness, Fatigue, Hypotension, Mental Status Changes, Petechiae, Rash Erythematous, Thrombocytopenia
Adverse event was reported on Jun 14, 2010 by a Female patient taking Septra (View Usage) (Dosage: 800 Mg, Bid) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 88 years of age, weighting 127.9 lb, After Septra was administered, patient had the following side effects: bradycardia, decreased appetite, dizziness (What is dizziness?), fatigue, hypotension, mental status changes, petechiae, rash erythematous, thrombocytopenia. Patient was hospitalized.

6725242-1 | Electrocardiogram Qt Prolonged, Intentional Overdose, Loss Of Consciousness
on May 03, 2010 Male patient from TURKEY , 17 years of age, was diagnosed with suicide attempt and was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, intentional overdose, loss of consciousness. Septra dosage: 24 Tablets (1820 Mg/9600 Mg), Single. During the same period patient was treated with PROPAFENONE HCL (20 Tablets (6000 Mg), Single) (View Propafenone Hcl Review and Propafenone Hcl Label ).

6676139-7 | Blood Bilirubin Increased, Chromaturia, Fatigue, Hepatitis, Hypertension, Intestinal Obstruction, Jaundice, Liver Injury, Pyrexia
on Apr 02, 2010 Male patient from UNITED STATES , weighting 135.0 lb, was diagnosed with acne (What is acne?) and was treated with Septra (View Usage). Patient had the following side effects: blood bilirubin increased, chromaturia, fatigue, hepatitis (What is hepatitis?), hypertension, intestinal obstruction, jaundice (What is jaundice?), liver injury, pyrexia. Septra dosage: 800/160 Mg, Bid. During the same period patient was treated with MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6663111-6 | Erythema, Immune Reconstitution Syndrome, Nodule On Extremity, Pyrexia, Skin Lesion
Patient was taking Septra (View Usage). After Septra was administered, patient had the following side effects: erythema, immune reconstitution syndrome, nodule on extremity, pyrexia, skin lesion on Mar 29, 2010 from FRANCE Additional patient health information: Male patient , 55 years of age, was diagnosed with whipple's disease and. Septra dosage: 1 Df, Bid. During the same period patient was treated with CEFTRIAXONE (2 G, Qd) (View Ceftriaxone Review and Ceftriaxone Label ).

6633900-2 | Acute Febrile Neutrophilic Dermatosis, Anaemia, Asthenia, C-reactive Protein Increased, Chills, Conjunctival Discolouration, Infection, Lymphocytic Infiltration, Mucous Membrane Disorder
Adverse event was reported on Mar 08, 2010 by a Male patient taking Septra (View Usage) (Dosage: Unk) was diagnosed with gastrointestinal infection and. Location: TUNISIA , child 7 years of age, Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis, anaemia, asthenia, c-reactive protein increased, chills, conjunctival discolouration, infection (What is infection?), lymphocytic infiltration, mucous membrane disorder. Patient was hospitalized.

6617558-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Dizziness, Dysarthria, Haemolytic Anaemia, Headache, Hepatitis
on Mar 01, 2010 Male patient from UNITED STATES , 37 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Septra (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, dizziness (What is dizziness?), dysarthria, haemolytic anaemia, headache (What is headache?), hepatitis (What is hepatitis?). Septra dosage: 1 Df, Bid (every 12 Hours). Patient was hospitalized.

6522058-6 | Completed Suicide
on Dec 28, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with completed suicide and was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: completed suicide. Septra dosage: Unk. During the same period patient was treated with METFORMIN (Unk) (View Metformin Review and Metformin Label ), QUETIAPINE (Unk) (View Quetiapine Review and Quetiapine Label ), VENLAFAXINE HYDROCHLORIDE (Unk) (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), PIOGLITAZONE (Unk) (View Pioglitazone Review and Pioglitazone Label ).

6453204-0 | Dermatitis Bullous, Dermatitis Exfoliative, Dry Eye, Eye Discharge, Haematocrit Decreased, Hypoxia, Keratitis
Patient was taking Septra (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, dermatitis exfoliative, dry eye, eye discharge, haematocrit decreased, hypoxia, keratitis on Nov 16, 2009 from NIGERIA Additional patient health information: Female patient , 27 years of age, was diagnosed with cd4 lymphocytes decreased, prophylaxis, hiv infection (What is hiv infection?) and. Septra dosage: Unk. During the same period patient was treated with NEVIRAPINE (Unk) (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (Unk) (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6413522-9 | Aplasia Pure Red Cell, Glomerulonephritis Membranoproliferative, Normochromic Normocytic Anaemia, Parvovirus B19 Test, Thrombocytopenia, Weight Decreased
Adverse event was reported on Oct 14, 2009 by a Male patient taking Septra (View Usage) (Dosage: 1 Df, Qd) was diagnosed with renal failure chronic and. Location: UNITED STATES , weighting 158.1 lb, Patient had the following side effects: aplasia pure red cell, glomerulonephritis membranoproliferative, normochromic normocytic anaemia, parvovirus b19 test, thrombocytopenia, weight decreased. During the same period patient was treated with ARANESP (300 Mcg, Qw) (View Aranesp Review and Aranesp Label ).

6403581-1 | Anaphylactic Reaction
on Oct 15, 2009 Female patient from UNITED STATES , 31 years of age, was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: anaphylactic reaction. Septra dosage: 1 Tab Bid Po. Patient was hospitalized.

6395638-9 | C-reactive Protein Increased, Eosinophil Count Increased, Pyrexia, Rash Morbilliform, Toxic Skin Eruption, Type Iv Hypersensitivity Reaction
on Oct 01, 2009 Male patient from NETHERLANDS , 36 years of age, was diagnosed with antifungal prophylaxis and was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, eosinophil count increased, pyrexia, rash morbilliform, toxic skin eruption, type iv hypersensitivity reaction. Septra dosage: 960 Mg, Qd. During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), LOPERAMIDE OXIDE (View Loperamide Oxide Review and Loperamide Oxide Label ).

6384111-X | Arthralgia, Blister, Dizziness, Heart Rate Irregular, Leukocytoclastic Vasculitis, Nausea, Oedema Peripheral, Palpable Purpura, Petechiae
Patient was taking Septra (View Usage). Patient had the following side effects: arthralgia, blister, dizziness (What is dizziness?), heart rate irregular, leukocytoclastic vasculitis, nausea (What is nausea?), oedema peripheral, palpable purpura, petechiae on Sep 21, 2009 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with cellulitis (What is cellulitis?) and. Septra dosage: . During the same period patient was treated with ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), WARFARIN SODIUM (2.5 Mg, Qhs) (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL (25 Mg, Bid) (View Metoprolol Review and Metoprolol Label ), TORSEMIDE (10 Mg, Qd) (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6384110-8 | C-reactive Protein Increased, Eosinophil Count Increased, Pyrexia, Rash Morbilliform, Toxic Skin Eruption, Type Iv Hypersensitivity Reaction
Adverse event was reported on Sep 21, 2009 by a Male patient taking Septra (View Usage) (Dosage: 960 Mg, Qd) was diagnosed with prophylaxis and. Location: NETHERLANDS , 36 years of age, After Septra was administered, patient had the following side effects: c-reactive protein increased, eosinophil count increased, pyrexia, rash morbilliform, toxic skin eruption, type iv hypersensitivity reaction. During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), LOPERAMIDE OXIDE (View Loperamide Oxide Review and Loperamide Oxide Label ).

6370494-3 | Leukocytoclastic Vasculitis, Rash Pustular
on Sep 16, 2009 Female patient from SWITZERLAND , 48 years of age, was diagnosed with nephrolithiasis and was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis, rash pustular. Septra dosage: Unk.

6315146-0 | Hypotension, Nephritis, Pyrexia, Tachycardia
on Aug 11, 2009 Male patient from FRANCE , 31 years of age, was treated with Septra (View Usage). Patient had the following side effects: hypotension, nephritis, pyrexia, tachycardia. Septra dosage: Unk. Patient was hospitalized.

6302839-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Cellulitis, Chest Pain, Chills, Myalgia, Pyrexia
Patient was taking Septra (View Usage). After Septra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, cellulitis (What is cellulitis?), chest pain (What is chest pain?), chills, myalgia, pyrexia on Aug 04, 2009 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 252.0 lb, was diagnosed with cellulitis (What is cellulitis?), hyperlipidaemia and. Septra dosage: 160/800 Mg, Bid. During the same period patient was treated with LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), VALPROIC ACID (1500 Mg, Qd) (View Valproic Acid Review and Valproic Acid Label ), RISPERDAL (3 Mg, Bid) (View Risperdal Review and Risperdal Label ), FAMOTIDINE (20 Mg, Bid) (View Famotidine Review and Famotidine Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), ACETAMINOPHEN (650 Mg, Prn) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6282116-0 | Fatigue, Lethargy, Nausea
Adverse event was reported on Jun 01, 2009 by a Male patient taking Septra (View Usage) (Dosage: Unk) was diagnosed with urinary tract infection (What is urinary tract infection?), osteoarthritis (What is osteoarthritis?) and. Location: UNITED STATES , 84 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, lethargy, nausea (What is nausea?). During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

6282115-9 | Tooth Discolouration
on Sep 17, 2008 Female patient from UNITED STATES , 21 years of age, weighting 125.0 lb, was diagnosed with acne (What is acne?) and was treated with Septra (View Usage). Patient had the following side effects: tooth discolouration. Septra dosage: Unk, Bid.

6282113-5 | Hypersensitivity
on May 14, 2009 Female patient from UNITED STATES , 80 years of age, was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: hypersensitivity. Septra dosage: .

6282110-X | Abdominal Pain Upper, Arthralgia, Arthritis, Feeling Abnormal, Malaise, Muscular Weakness, Myalgia, Nausea
Patient was taking Septra (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, arthralgia, arthritis (What is arthritis?), feeling abnormal, malaise, muscular weakness, myalgia, nausea (What is nausea?) on Dec 10, 2008 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with antimicrobial susceptibility test resistant, arthritis (What is arthritis?) and. Septra dosage: Unk. During the same period patient was treated with CELEBREX (Unk) (View Celebrex Review and Celebrex Label ).

6282109-3 | Hypersensitivity, Leukopenia, Rash, Rash Erythematous, Thrombocytopenia
Adverse event was reported on Nov 26, 2008 by a Female patient taking Septra (View Usage) (Dosage: Unk) was diagnosed with gastrointestinal infection, hypertension and. Location: UNITED STATES , 68 years of age, weighting 135.0 lb, Patient had the following side effects: hypersensitivity, leukopenia, rash (What is rash?), rash erythematous, thrombocytopenia. During the same period patient was treated with ATENOLOL (Unk) (View Atenolol Review and Atenolol Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6260521-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Chest Pain, Myalgia, Pyrexia, Rhabdomyolysis
on Jun 25, 2009 Female patient from UNITED STATES , 46 years of age, was diagnosed with cellulitis (What is cellulitis?), blood cholesterol increased and was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, chest pain (What is chest pain?), myalgia, pyrexia, rhabdomyolysis. Septra dosage: 160/800 Mg, Bid. During the same period patient was treated with LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), VALPROIC ACID (Unk) (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6240255-4 | Influenza Like Illness
on Jun 18, 2009 Male patient from UNITED STATES , 53 years of age, weighting 145.0 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: influenza like illness. Septra dosage: 1 Tablet Twice A Day Po.

6191434-6 | Hyperkalaemia, Ventricular Arrhythmia
Patient was taking Septra (View Usage). Patient had the following side effects: hyperkalaemia, ventricular arrhythmia on May 04, 2009 from UNITED STATES Additional patient health information: Female patient , 86 years of age, was diagnosed with wound infection staphylococcal, cellulitis (What is cellulitis?), hypertension and. Septra dosage: 320/1600 Mg, Bid. During the same period patient was treated with LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6154308-2 | Lymphadenopathy, Pruritus, Pyrexia, Skin Exfoliation, Skin Lesion
Adverse event was reported on Apr 06, 2009 by a Male patient taking Septra (View Usage) (Dosage: Unk) . Location: MEXICO , 29 years of age, After Septra was administered, patient had the following side effects: lymphadenopathy, pruritus, pyrexia, skin exfoliation, skin lesion.

6148229-9 | Asthenia, Cyanosis, Dyspnoea, Fatigue, Hypoxia, Somnolence, Sulphaemoglobinaemia
on Mar 30, 2009 Female patient from UNITED STATES , 28 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cyanosis, dyspnoea, fatigue, hypoxia, somnolence, sulphaemoglobinaemia. Septra dosage: Unk. During the same period patient was treated with SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), IRON (View Iron Review and Iron Label ). Patient was hospitalized.

6133164-2 | Platelet Count Decreased
on Mar 25, 2009 Female patient from UNITED STATES , child 11 years of age, weighting 80.00 lb, was diagnosed with infection (What is infection?) and was treated with Septra (View Usage). Patient had the following side effects: platelet count decreased. Septra dosage: .

6113054-1 | Acute Febrile Neutrophilic Dermatosis, Arthralgia, Pyrexia, Rash Erythematous, Rash Vesicular
Patient was taking Septra (View Usage). After Septra was administered, patient had the following side effects: acute febrile neutrophilic dermatosis, arthralgia, pyrexia, rash erythematous, rash vesicular on Mar 02, 2009 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with stenotrophomonas infection, escherichia infection, pyrexia, chills, pain (What is pain?), pleural effusion and. Septra dosage: Unk. During the same period patient was treated with MOXIFLOXACIN HCL (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), CIPROFLOXACIN (Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ), TIGECYCLINE (View Tigecycline Review and Tigecycline Label ). Patient was hospitalized.

6103317-8 | Atrioventricular Block First Degree, Blood Creatinine Increased, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram T Wave Peaked, Hyperkalaemia
Adverse event was reported on Feb 24, 2009 by a Female patient taking Septra (View Usage) (Dosage: 800/160 Mg, Bid) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: atrioventricular block first degree, blood creatinine increased, electrocardiogram qrs complex prolonged, electrocardiogram t wave peaked, hyperkalaemia. During the same period patient was treated with ISOSORBIDE (60 Mg, Qd) (View Isosorbide Review and Isosorbide Label ), GEMFIBROZIL (600 Mg, Bid) (View Gemfibrozil Review and Gemfibrozil Label ), TORSEMIDE (20 Mg, Qd) (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6093880-8 | Haemorrhage, Pain Of Skin, Paraesthesia
on Feb 24, 2009 Male patient from UNITED STATES , 56 years of age, weighting 280.0 lb, was diagnosed with ear pain and was treated with Septra (View Usage). Patient had the following side effects: haemorrhage, pain of skin, paraesthesia. Septra dosage: .

6093762-1 | Anorexia, Cholestasis, Chromaturia, Fatigue, Hypoalbuminaemia, Jaundice, Malaise, Nausea, Normochromic Normocytic Anaemia
on Feb 16, 2009 Female patient from BRAZIL , 33 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: anorexia, cholestasis, chromaturia, fatigue, hypoalbuminaemia, jaundice (What is jaundice?), malaise, nausea (What is nausea?), normochromic normocytic anaemia. Septra dosage: Unk. Patient was hospitalized.

6057537-1 | Apraxia, Balance Disorder, Delirium, Disorientation, Dysstasia, Fall, Gait Disturbance, Illusion, Normochromic Normocytic Anaemia
Patient was taking Septra (View Usage). Patient experienced the following unwanted or unexpected effects: apraxia, balance disorder, delirium, disorientation, dysstasia, fall (What is fall?), gait disturbance, illusion, normochromic normocytic anaemia on Jan 20, 2009 from AUSTRALIA Additional patient health information: Male patient , 82 years of age, was diagnosed with stenotrophomonas infection, evidence based treatment, pneumonia staphylococcal, serratia infection, depression (What is depression?) and. Septra dosage: 2 Df (800 Mg/160 Mg), Bid. During the same period patient was treated with AMPICILLIN SODIUM (1 G, Qid) (View Ampicillin Sodium Review and Ampicillin Sodium Label ), PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (4 G/0.5 G, Q8h) (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ), CEFEPIME (2 G, Bid) (View Cefepime Review and Cefepime Label ), ESOMEPRAZOLE (20 Mg, Qd) (View Esomeprazole Review and Esomeprazole Label ).

6030654-8 | Acute Febrile Neutrophilic Dermatosis, Alpha 2 Globulin Increased, Blister, C-reactive Protein Increased, Cheilitis, Conjunctivitis, Cough, Eyelid Oedema
Adverse event was reported on Dec 29, 2008 by a Female patient taking Septra (View Usage) (Dosage: ) was diagnosed with vaginal infection and. Location: FRANCE , 40 years of age, Patient had the following side effects: acute febrile neutrophilic dermatosis, alpha 2 globulin increased, blister, c-reactive protein increased, cheilitis, conjunctivitis, cough, eyelid oedema.

6013363-0 | Completed Suicide
on Dec 16, 2008 Female patient from UNITED STATES , 40 years of age, was treated with Septra (View Usage). After Septra was administered, patient had the following side effects: completed suicide. Septra dosage: Unk. During the same period patient was treated with DIDANOSINE (Unk) (View Didanosine Review and Didanosine Label ), RITONAVIR (Unk) (View Ritonavir Review and Ritonavir Label ), ATAZANAVIR SULFATE (Unk) (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), EMTRICITABINE W/TENOFOVIR (Unk) (View Emtricitabine W/tenofovir Review and Emtricitabine W/tenofovir Label ), BUTALBITAL ACETAMINOPHEN AND CAFFEINE (Unk) (View Butalbital Acetaminophen And Caffeine Review and Butalbital Acetaminophen And Caffeine Label ), HYDROMORPHONE HCL (Unk) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ).

6013358-7 | Completed Suicide
on Dec 16, 2008 Female patient from UNITED STATES , 26 years of age, was treated with Septra (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Septra dosage: Unk. During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE (Unk) (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), QUETIAPINE FUMARATE (Unk) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), DICYCLOMINE (Unk) (View Dicyclomine Review and Dicyclomine Label ), MUSCLE RELAXANTS (Unk) (View Muscle Relaxants Review and Muscle Relaxants Label ).

6003092-1 | Pruritus
Patient was taking Septra (View Usage). Patient had the following side effects: pruritus on Dec 15, 2008 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 170.0 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Septra dosage: One Pill Twice Daily Po.